mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.06 |
0.3 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
AZD8055 |
GDSC1000 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.3 |
mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |